These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23345993)

  • 1. Anti-citrullinated protein antibodies in rheumatoid arthritis: a bridge between genetic predisposition and autoimmunity.
    Kim HR
    Korean J Intern Med; 2013 Jan; 28(1):25-8. PubMed ID: 23345993
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-citrullinated peptide/protein antibodies and structural prognosis of rheumatoid arthritis: quantity versus quality.
    Meyer O
    J Rheumatol; 2012 Apr; 39(4):675-6. PubMed ID: 22467946
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of anti-cyclic citrullinated peptide and rheumatoid factor in diagnosis of rheumatoid arthritis.
    Cheah TE; Sockalingam S
    Int J Rheum Dis; 2012 Feb; 15(1):e1. PubMed ID: 22324958
    [No Abstract]   [Full Text] [Related]  

  • 4. Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
    Holers VM
    Nat Clin Pract Rheumatol; 2006 Aug; 2(8):400-1. PubMed ID: 16932728
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significance.
    Demoruelle MK; Deane K
    Curr Rheumatol Rep; 2011 Oct; 13(5):421-30. PubMed ID: 21713412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Greater prevalence of seropositivity for anti-cyclic citrullinated peptide antibody in unaffected first-degree relatives in multicase rheumatoid arthritis-affected families.
    Kim SK; Bae J; Lee H; Kim JH; Park SH; Choe JY
    Korean J Intern Med; 2013 Jan; 28(1):45-53. PubMed ID: 23345996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticyclic citrullinated peptide antibody-negative rheumatoid arthritis: clues to disease pathogenesis.
    Crow MK
    Curr Rheumatol Rep; 2008 Jul; 10(3):165-7. PubMed ID: 18638423
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of anti-cyclic citrullinated peptide and anti-Sa/citrullinated vimentin autoantibodies in rheumatoid arthritis.
    Rodríguez-Mahou M; López-Longo FJ; Sánchez-Ramón S; Estecha A; García-Segovia A; Rodríguez-Molina JJ; Carreño L; Fernández-Cruz E
    Arthritis Rheum; 2006 Aug; 55(4):657-61. PubMed ID: 16874789
    [No Abstract]   [Full Text] [Related]  

  • 9. [Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].
    Bas S
    Rev Med Suisse; 2005 Mar; 1(10):674, 677-8, 680 passim. PubMed ID: 15828370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients.
    Zhu T; Feng L
    Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.
    Aggarwal R; Liao K; Nair R; Ringold S; Costenbader KH
    Arthritis Rheum; 2009 Nov; 61(11):1472-83. PubMed ID: 19877103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with anti-tumour necrosis factor agents.
    Russell AS; Maksymowych WP; de Silva M
    Ann Rheum Dis; 2005 Dec; 64(12):1807. PubMed ID: 16284357
    [No Abstract]   [Full Text] [Related]  

  • 14. The immunopathogenesis of rheumatoid arthritis.
    Imboden JB
    Annu Rev Pathol; 2009; 4():417-34. PubMed ID: 18954286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to citrullinated proteins in arthritis: pathology and promise.
    Klareskog L; Widhe M; Hermansson M; Rönnelid J
    Curr Opin Rheumatol; 2008 May; 20(3):300-5. PubMed ID: 18388522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities.
    Ioan-Facsinay A; el-Bannoudi H; Scherer HU; van der Woude D; Ménard HA; Lora M; Trouw LA; Huizinga TW; Toes RE
    Ann Rheum Dis; 2011 Jan; 70(1):188-93. PubMed ID: 20736390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.
    Ménard HA
    J Rheumatol; 2009 Apr; 36(4):663-4. PubMed ID: 19342718
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of Anti-Citrullinated Protein Antibodies and IgM Rheumatoid Factor in First-Degree Relatives of Dutch Rheumatoid Arthritis Patients.
    Maijer KI; Gerlag DM; Tak PP
    Arthritis Rheumatol; 2015 Dec; 67(12):3324-6. PubMed ID: 26315149
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-cyclic citrullinated peptide antibody in rheumatic diseases other than rheumatoid arthritis.
    Matsui T; Shimada K; Tohma S
    Clin Rheumatol; 2006 Jul; 25(4):610-1. PubMed ID: 16283420
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical interest of autoantibodies directed against citrullinated peptides in Indian patients with rheumatoid arthritis.
    Goëb V
    Indian J Med Sci; 2009 Mar; 63(3):89-91. PubMed ID: 19359775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.